Biogen (HAM:IDP) Dividends per Share: €0.00 (TTM As of Mar. 2026)

What is Biogen Dividends per Share?

Biogen HAM:IDP -1.13% 74 Dividends per Share is €0.00 as of Mar. 2026. GuruFocus rates HAM:IDP with a GF Score™ of 74/100 and a GF Value™ of €167.59 (Fairly Valued). The stock has 7 warning signs investors should review.

Biogen's dividends per share for the three months ended in Mar. 2026 was €0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2026 was €0.00. Its Dividend Payout Ratio for the three months ended in Mar. 2026 was 0.00. As of today, Biogen's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Biogen (HAM:IDP) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Biogen's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2026 )	/	EPS without NRI (Q: Mar. 2026 )
	=	0	/	3.088
	=	0.00

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biogen Dividends per Share Related Terms

Biogen Dividends per Share Historical Data

* Premium members only.

The historical data trend for Biogen's Dividends per Share can be seen below:

Biogen Dividends per Share Chart

Biogen Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Dividends per Share

Get a 7-Day Free Trial

0.00

Biogen Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Dividends per Share	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

HAM:IDP vs OGN, AMRN, SCLX: Dividends per Share Comparison

For the Drug Manufacturers - General subindustry, Biogen's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biogen Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biogen's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Biogen's Dividend Yield % falls into.

Save Embed

74GF Score

Biogen Inc HAM:IDP

Dividends per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Biogen Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →

What does a Dividends per Share of €0.00 mean?

Biogen (HAM:IDP) has a Dividends per Share of €0.00 as of Mar. 2026. Dividends per share represents the per-share amount paid as dividends. View historical data on Biogen and its competitors.

Is Biogen's Dividends per Share too high?

Biogen's current Dividends per Share is €0.00. Overall, Biogen has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Biogen's Dividends per Share compare to OGN and AMRN?

Biogen's Dividends per Share of €0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Dividends per Share for a Drug Manufacturers company?

A good Dividends per Share depends on the Drug Manufacturers industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Dividends per Share mean?

A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Biogen and its competitors. Biogen's current Dividends per Share is €0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Biogen stock overvalued right now?

Based on GuruFocus' analysis, Biogen (HAM:IDP) is currently considered Fairly Valued. The stock's GF Value™ is €167.59, compared to a current price of €171.86 — trading 2.5% above its estimated fair value. The current Dividends per Share is €0.00. Biogen's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Dividends per Share calculated?

Dividends per Share is calculated from a company's financial statements. For Biogen (HAM:IDP), the current Dividends per Share is €0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biogen (HAM:IDP) Overvalued in 2026?

Based on GuruFocus' analysis, Biogen stock appears to be overvalued. The current stock price of €171.86 is trading 2.5% above its estimated GF Value™ of €167.59. GuruFocus considers Biogen to be Fairly Valued.

Key valuation signals for HAM:IDP:

Dividends per Share: €0.00
GF Value™: €167.59 vs. price of €171.86 (2.5% above fair value)
GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the HAM:IDP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biogen Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies OGN AMRN SCLX MIRA NSRX MDCX BMY PFE GILD LLY JNJ ABBV XSWX:ROP MRK XSWX:NOVN LSE:AZN OCSE:NOVO B AMGN LSE:GSK XPAR:SAN

Other Exchanges BIIB:USA BIIB:Mexico BIIB_KZ:Kazakhstan 1BIIB:Italy 0R1B:UK BIIB34:Brazil BIIB:Austria BIIB:Argentina

Address 225 Binney Street, Cambridge, MA, USA, 02142

Website https://www.biogen.com

Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 40% of total revenue in 2025. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (19% of total in 2025), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).

74GF Score

Get the complete analysis for HAM:IDP

Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€171.86

Price

€167.59

GF Value

View HAM:IDP Analysis

See Dividends per Share data for all stocks →